×

Levin: Immigration fears will inhibit the 'best of the best'

4:50 PM ET Tue, 7 Feb 2017

Jeremy Levin, Ovid Therapeutics CEO, former Teva Pharmaceuticals CEO, speaks to CNBC's Meg Tirrell about how President Trump's immigration plans may impact the biotech industry.